Fauci expects uptick in vaccine administration after FDA OKs Pfizer shot

Dr. Anthony Fauci says he's hoping for an uptick in the administration of Covid-19 vaccinations following US government approval of the Pfizer vaccine

Anthony Fauci
Anthony Fauci, director of the National Institute for Allergy and Infectious Disease. Photo: Reuters
AP Washington
1 min read Last Updated : Aug 24 2021 | 7:50 PM IST

Dr. Anthony Fauci says he's hoping for an uptick in the administration of COVID-19 vaccinations following U.S. government approval of the Pfizer vaccine.

The top infectious disease expert in the U.S. says the Food and Drug Administration's decision Monday should encourage people who cited lack of approval as a reason for not getting vaccinated. The FDA previously had cleared the Pfizer shots for use on an emergency basis.

Fauci told NBC's Today Show that FDA approval will mean more enthusiasm for vaccine mandates by workplaces, colleges and universities, and the military. He says it will help boost U.S. vaccination rates.

The FDA's decision clears Pfizer to advertise the vaccine, which Fauci says should help. Government data show just under half of the U.S. population remains unvaccinated.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PfizerCoronavirus VaccineUS FDA

First Published: Aug 24 2021 | 7:50 PM IST

Next Story